BioXcel Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BTAI and other ETFs, options, and stocks.About BTAI
BioXcel Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of artificial intelligence solutions in neuroscience and immuno-oncology. It also focuses on utilizing technology and research to develop therapeutics solutions.
CEOVimal D. Mehta
CEOVimal D. Mehta
Employees37
Employees37
HeadquartersNew Haven, Connecticut
HeadquartersNew Haven, Connecticut
Founded2017
Founded2017
Employees37
Employees37
BTAI Key Statistics
Market cap44.18M
Market cap44.18M
Price-Earnings ratio-0.23
Price-Earnings ratio-0.23
Dividend yield—
Dividend yield—
Average volume2.39M
Average volume2.39M
High today$3.19
High today$3.19
Low today$2.94
Low today$2.94
Open price$2.98
Open price$2.98
Volume1.36M
Volume1.36M
52 Week high$13.28
52 Week high$13.28
52 Week low$1.17
52 Week low$1.17
BTAI News
TipRanks 6h
BioXcel Therapeutics regains compliance with NasdaqBioXcel Therapeutics (BTAI) announced that it has received written notice from the Listing Qualifications Department of The Nasdaq Stock Market that the Company...
TipRanks 3d
Bioxcel Therapeutics Files Current Report on Form 8-KElevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...
TipRanks 6d
BioXcel Therapeutics price target raised to $4 from $2 at MizuhoMizuho raised the firm’s price target on BioXcel Therapeutics (BTAI) to $4 from $2 and keeps a Neutral rating on the shares. The firm cites the positive Phase 3...
People also own
Based on the portfolios of people who own BTAI. This list is generated using Robinhood data, and it’s not a recommendation.